262 related articles for article (PubMed ID: 38235907)
1. Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome.
Gonzalez-Garay AG; Serralde-Zúñiga AE; Velasco Hidalgo L; Flores García NC; Aguirre-Salgado MI
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD011039. PubMed ID: 38235907
[TBL] [Abstract][Full Text] [Related]
2. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
5. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
Best LM; Freeman SC; Sutton AJ; Cooper NJ; Tng EL; Csenar M; Hawkins N; Pavlov CS; Davidson BR; Thorburn D; Cowlin M; Milne EJ; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013103. PubMed ID: 31513287
[TBL] [Abstract][Full Text] [Related]
6. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
7. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.
Colli A; Fraquelli M; Prati D; Casazza G
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013532. PubMed ID: 37278488
[TBL] [Abstract][Full Text] [Related]
9. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.
Simonetti RG; Perricone G; Nikolova D; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004039. PubMed ID: 31251387
[TBL] [Abstract][Full Text] [Related]
10. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
[TBL] [Abstract][Full Text] [Related]
11. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticosteroids for people with alcoholic hepatitis.
Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001511. PubMed ID: 30964545
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic sphincterotomy for adults with biliary sphincter of Oddi dysfunction.
Naing C; Ni H; Aung HH; Pavlov CS
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD014944. PubMed ID: 38517086
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics for treatment of leptospirosis.
Win TZ; Han SM; Edwards T; Maung HT; Brett-Major DM; Smith C; Lee N
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD014960. PubMed ID: 38483092
[TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
[TBL] [Abstract][Full Text] [Related]
16. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
[TBL] [Abstract][Full Text] [Related]
17. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome.
Choi GH; Wieland LS; Lee H; Sim H; Lee MS; Shin BC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011215. PubMed ID: 30521680
[TBL] [Abstract][Full Text] [Related]
18. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
19. Acupuncture for chronic hepatitis B.
Kong Z; Liang N; Yang GL; Zhang Z; Liu Y; Yang Y; Liu YX; Wang QG; Zhang F; Zhang HY; Nikolova D; Jakobsen JC; Gluud C; Liu JP
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013107. PubMed ID: 31436846
[TBL] [Abstract][Full Text] [Related]
20. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
